Sorry, you need to enable JavaScript to visit this website.

BOSULIF® (bosutinib) Principal Display Panel

PRINCIPAL DISPLAY PANEL - 100 mg Bottle Label

Pfizer

NDC 0069-0135-01

Bosulif®
(bosutinib) tablets

100 mg*

Do not crush or cut tablet
For Oncology Use Only

120 Tablets

Rx only

PRINCIPAL DISPLAY PANEL - 100 mg Bottle Label

PRINCIPAL DISPLAY PANEL - 500 mg Bottle Label

Pfizer

NDC 0069-0136-01

Bosulif®
(bosutinib) tablets

500 mg*

Do not crush or cut tablet
For Oncology Use Only

30 Tablets

Rx only

PRINCIPAL DISPLAY PANEL - 500 mg Bottle Label

PRINCIPAL DISPLAY PANEL - 400 mg Tablet Bottle Label

Pfizer

NDC 0069-0193-01

Bosulif®
(bosutinib) tablets

400 mg*

Do not crush or cut tablet
For Oncology Use Only

30 Tablets

Rx only

PRINCIPAL DISPLAY PANEL - 400 mg Tablet Bottle Label

What's New

No Current Announcements.

Contact Pfizer Medical

Report an Adverse Event
1-800-438-1985

Search

Please enter your search term(s) for BOSULIF®